Key facts
- This page summarizes Kevin Unger's Form 4 filing for ORTHOPEDIATRICS CORP (KIDS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Jun 2022, 08:13.
Kevin Unger - 01 Jun 2022 Form 4 Insider Report for ORTHOPEDIATRICS CORP (KIDS)
- Reporting relationship
- Director
- Issuer ticker
- KIDS
- Reported as of
- 01 Jun 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Jun 2022, 08:13:30 UTC
- Prior SEC filing
- 04 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel J. Gerritzen, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kevin Unger filed Form 4 for ORTHOPEDIATRICS CORP (KIDS) on 03 Jun 2022.
Change
- Previous filing in this sequence was filed on 04 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KIDS
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +1,691
- Change %
- +30%
- Price
- $0.000000
- Shares after
- 7,291
- Date
- 01 Jun 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Includes restricted stock awards totaling 3,092 shares.